Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?

Prabha, Praisy K; Prakash, Ajay; Medhi, Bikash

Prabha, Praisy K; Prakash, Ajay; Medhi, Bikash.

Afiliação

Prabha PK; Department of Neurology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India.
Prakash A; Department of Pharmacology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India.
Medhi B; Department of Pharmacology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India.

Indian J Med Res ; 157(1): 100-103, 2023 01.

Article em En | MEDLINE | ID: mdl-37040235

Assuntos

COVID-19; Pró-Fármacos; Humanos; Tratamento Farmacológico da COVID-19; Monofosfato de Adenosina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google